1. Noordenbos W. Pain. Amsterdam: Elsevier, 1959.

2. Gracely RH, Dubner R. Pain assessment in humans—a reply to Hall. Pain 1981; 11(1):109-120.

3. Price Dd et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002; 99(1-2):49-59.

4. Myles PS et al. The pain visual analog scale: is it linear or nonlinear? Anesth Analg 1999; 89(6): 1517-1520.

5. Price DD et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17(1):45-56.

6. Price DD et al. The N-methyl-d-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59(2):165-174.

7. Price DD, Riley JL, Wade JB. Psychophysical approaches to the measurement of the dimensions and stages of pain. In: Turk DC, Melzack R, eds. Handbook of Pain Measurement. New York: The Guilford Press, 2001:115-134.

8. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain 2002; 98(1-2):205-216.

9. Price DD, Harkins SW. The combined use of visual analogue scales and experimental pain in providing standardized measurement of clinical pain. Clin J Pain 1987; 3:1-8.

10. Price DD et al. A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain. Pain 1986; 24(2):197-203.

11. Price DD. Psychological Mechanisms of Pain and Analgesia. Seattle: IASP Press, 1999.

12. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci USA 2003; 100(14):8538-8542.

13. Price DD et al. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994; 56(2):217-226.

14. Dworkin RH et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113(1-2):9-19.

15. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: The Guilford Press, 2001:135-151.

16. Yeomans DC, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 1996; 68(1):141-150.

17. Price DD, Long S, Huitt C. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992; 49(2):163-173.

18. Janig W, Stanton-Hicks M. Reflex sympathetic dystrophy: a reappraisal. Seattle: IASP Press, 1996.

19. Campbell JN, Raja SN, Meyer RA. Painful sequelae of nerve injury. In: Dubner R, Gebhart GF, Bond MR, eds. Pain Research and Clinical Management. New York: Elsevier, 1988:135-143.

20. Meyer RA, Campbell JN. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science 1981; 213(4515):1527-1529.

21. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51(2):175-194.

22. Staud R et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91(1-2):165-175.

23. Staud R et al. Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003; 105(1-2):215-222.

24. Staud R et al. Maintenance of windup of second pain requires less frequent stimulation in fibromyal-gia patients compared to normal controls. Pain 2004; 110(3):689-696.

25. Vierck CJ Jr et al. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2001; 2(6):334-344.

26. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 10(6): 965-968.

27. Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20(3):469-474.

28. Russell IJ et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37(11):1593-1601.

29. Price DD. Characteristics of second pain and flexion reflexes indicative of prolonged central summation. Exp Neurol 1972; 37(2):371-387.

30. Price DD et al. Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 1977; 3(1):57-68.

31. Vierck CJ Jr et al. Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol 1997; 78(2):992-1002.

32. Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain 1999; 79(1):75-82.

33. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206:97-99.

34. Staud R et al. Effects of the NMDA receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal controls. J Pain 2005; 6(5):323-332.

35. Merritt AM et al. Evaluation of method to experimentally induce colic in horses and the effects of acupuncture applied at the Guan-yuan-shu (similar to BL-21) acupoint. Am J Vet Res 2002; 66(5): 897-906.

36. Maixner W et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998; 76(1-2):71-81.

37. Price DD, Bennett GJ, Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989; 36(3):273-288.

38. Arendt-Nielsen L. Induction and assessment of experimental pain from human skin, muscle, and viscera. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z, eds. Proceedings of the 8th World Congress on Pain. Seattle: IASP Press, 1997:393.

39. Collins WF, Nulsen FE, Randt CT. Relation of peripheral nerve fiber size and sensation in man. Arch Neurol (Chic) 1960; 3:381-385.

40. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93(1):7-14.

41. Mertz H et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109(1):40-52.

42. Naliboff BD et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41(4):505-512.

43. Accarino AM, Azpiroz F, Malagelada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995; 108(3):636-643.

44. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93(4):727-733.

45. Whitehead WE et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenter-ology 1990; 98(5 Pt 1):1187-1192.

46. Zighelboim J et al. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995; 40(4):819-827.

47. Bouin M et al. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?. Dig Dis Sci 2001; 46(11):2542-2548.

48. Chang L et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84(2-3):297-307.

49. Dunphy RC et al. Visceral and cutaneous hypersensitivity in Persian Gulf War veterans with chronic gastrointestinal symptoms. Pain 2003; 102(1-2):79-85.

50. Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci 2002; 47(8):1716-1722.

51. Verne GN et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103(1-2):99-110.

52. Verne GN et al. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105(1-2):223-230.

53. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99(6):1688-1704.

54. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107(1):271-293.

55. Al Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119(5): 1276-1285.

56. Zhou Q et al. Visceral somatic convergence in TNBS induced colitis in rats, J Pain 2005; 7(4):330.

57. Mertz H et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118(5):842-848.

58. Naliboff BD et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63(3):365-375.

59. Silverman DH, Phelps ME. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?. J Nucl Med 2000; 41(11):1929-1932.

60. Yuan YZ et al. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol 2003; 9(6):1356-1360.

61. Price DD et al. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain 1998; 14(3):216-226.

62. Vase L et al. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003; 105(1-2):17-25.

63. Vase L, Riley JL III, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002; 99(3):443-452.

64. Verne GN, Price DD. Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep 2002; 4(4):322-328.

65. Verne GN, Sen A, Price DD. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain 2005; 6(8):493-496.

66. Robinson ME, Riley JL. Negative emotion in pain. In: Gatchel R, Turk D, eds. Psychosocial Factors in Pain. New York: Guilford Press, 1998.

67. Ploghaus A et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001; 21(24):9896-9903.

68. Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain 2000; 84(1):65-75.

69. Rhudy JL, Meagher MW. Negative affect: effects on an evaluative measure of human pain. Pain 2003; 104(3):617-626.

70. Zelman DC et al. The effects of induced mood on laboratory pain. Pain 1991; 46(1):105-111.

71. McCracken LM, Gross RT. The role of pain-related anxiety reduction in the outcome of multidisci-plinary treatment for chronic low back pain: preliminary results. J Occup Rehabil 1998; 8:179-189.

72. Vase L et al. The contributions of changes in expected pain levels and desire for pain relief to placebo analgesia. In: Price DD, Bushnell MC, eds. Psychological Methods of Pain Control: Basic Science and Clinical Perspectives. Seattle, WA: IASP Press, 2004:207-232.

Was this article helpful?

0 0
Baby Sleeping

Baby Sleeping

Everything You Need To Know About Baby Sleeping. Your baby is going to be sleeping a lot. During the first few months, your baby will sleep for most of theday. You may not get any real interaction, or reactions other than sleep and crying.

Get My Free Ebook

Post a comment